Financial News Feed

Previous Hold Today AGIO ranks #2056 as HOLD CANDIDATE. Next Hold
Today AGIO ranks #2056 as HOLD CANDIDATE.

AGIO stock Agios Pharmaceuticals

AGIO stock
Agios Pharmaceuticals

Big Money Sentiment decreased to 1.09 in 2018 Q3. It has change of 0.39, from 2018Q2's 1.48. The ratio worsened due to Agios Pharmaceuticals, Inc. positioning:...

Read more

After a recent reading, we have noted that the longer-term MACD oscillator indicator signal on shares of Agios Pharmaceutical (AGIO) is pointing to a Sell. The MACD is generally used to gauge bullish ...

Read more

Big Money Sentiment decreased to 1.09 in 2018 Q3. It has change of 0.39, from 2018Q2's 1.48. The ratio worsened due to Agios Pharmaceuticals, Inc. positioning:...

Read more

Looking back at some historical performance on shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), we can see that the stock price performance for the last week is 2.29%. Tracking back further over t...

Read more

Investors may be watching the technical signals on shares of Agios Pharmaceutical (AGIO). Looking at the 50-day moving average vs price signal, the reading is measured at Sell. This indicator is used ...

Read more

Dimensional Fund Advisors LP increased its holdings in Agios Pharmaceuticals Inc (NASDAQ:AGIO) by 41.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange C...

Read more

Agios Pharmaceutical (AGIO) shares have popped up on the radar as the RMI or Relative Momentum Indicator has trended higher over the past 5 sessions. As the momentum builds, we will be closely watchin...

Read more

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we’ll take a look at the Price to Cash Flow ratio of Domtar Corporation (NYSE:...

Read more

Ichimoku traders are closely watching shares of Agios Pharmaceutical (AGIO) as the equity’s price has tipped below the Tenkan moving average line, creating an environment ripe for a potential near-t...

Read more

Focusing on shares of Agios Pharmaceutical (AGIO), we note that the opinion signal on the stock is presently 16% Sell. For the last month, the opinion signal is recorded as 96% Sell. This is the combi...

Read more

Agios Pharmaceutical (AGIO) shares have popped up on trader’s radar screens as the Aroon Oscillator signal has revealed an upward trend that is building. The Aroon indicator (“Aroon up” and “A...

Read more

Investors sentiment decreased to 1.09 in 2018 Q3. Its down 0.39, from 1.48 in 2018Q2. It worsened, as 22 investors sold Agios Pharmaceuticals, Inc. shares...

Read more

Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Thursday. A number of other research anal...

Read more

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the ...

Read more

Investors sentiment decreased to 1.09 in 2018 Q3. Its down 0.39, from 1.48 in 2018Q2. It worsened, as 22 investors sold Agios Pharmaceuticals, Inc. shares...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank